Address
40, Tony Garnier
Lyon, Rhone
70130, France
Contact
Lucia, Pagani+330672127516
lucia.pagani@bioaster.org
Website
HoloMoA
Holographic identification of mechanism of action of a drug
Unstaining, rapid, and reliable technology
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Yeasts
- Viruses
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
N.A.
Non for profit organization in the field of microbiology and infectious disease.
We do research in 4 fields: antimicrobials, vaccine, diagnostics, microbiota.
We have numerous technologies available: microscopy, microfluidics (organ on chip), microbiology wet lab, OMIC wet lab and data analysis, biostatistics, machine learning, data management, software development.
In silico design of antimicrobial peptides. This is a new technology aiming at tailor and/or optimize peptide for their antimicrobial capabilities, as well as other important characteristics (eg reduced toxicity).
